Pneumonia, Bacterial - 26 Studies Found Recruiting : Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia : Community Acquired Bacterial Pneumonia : 2016-01-27 : Drug: Delafloxacin Antibacteri Completed : A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia : Community-Acquired Bacterial Pneumonia Lung Infection of Indivi : 2011-04-27 : Drug: Ceftaroline Two consecut Recruiting : Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia : Community-acquired Bacterial Pneumonia : 2015-11-10 : Drug: Solithromycin Other Name Completed : Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia : Community-acquired Bacterial Pneumonia : 2012-12-20 : Drug: Solithromycin Other Name Completed : Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia : Community-acquired Bacterial Pneumonia : 2013-10-21 : Drug: Solithromycin Other Name Withdrawn : Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia : Community-Acquired Bacterial Pneumonia (CABP) : 2012-08-14 : Drug: Ceftaroline fosamil IV ceftaroline fosamil 600 mg infused over 60 (± 10) minutes every 12 hou Completed : The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP) : Pneumonia, Bacterial : 2010-08-16 : Drug: ampicillin sodium/sulbactam sodium ampicillin sodium/sulbactam sodium is administered 12g/day (3 g Withdrawn : Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization : Pneumonia, Bacterial : 2014-08-14 : Drug: Amikacin Fosfomycin Inhalation Solution Completed : Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia : Pneumonia, Bacterial : 2013-02-25 : Drug: Amikacin Inhalation Solution (BAY41-6551) Completed : Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia : Pneumonia, Bacterial : 2008-12-08 : Drug: Amikacin Inhalation Solution (BAY41-6551) <<< Previous | Next >>>
